These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 9727024)

  • 1. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
    Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
    J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
    Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
    J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons.
    Saito T; Ishiguro K; Onuki R; Nagai Y; Kishimoto T; Hisanaga S
    Biochem Biophys Res Commun; 1998 Nov; 252(3):775-8. PubMed ID: 9837783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.
    Tsai LH; Delalle I; Caviness VS; Chae T; Harlow E
    Nature; 1994 Sep; 371(6496):419-23. PubMed ID: 8090221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.
    Nikolic M; Dudek H; Kwon YT; Ramos YF; Tsai LH
    Genes Dev; 1996 Apr; 10(7):816-25. PubMed ID: 8846918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.
    Rideout HJ; Wang Q; Park DS; Stefanis L
    J Neurosci; 2003 Feb; 23(4):1237-45. PubMed ID: 12598612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation.
    Saito T; Onuki R; Fujita Y; Kusakawa G; Ishiguro K; Bibb JA; Kishimoto T; Hisanaga S
    J Neurosci; 2003 Feb; 23(4):1189-97. PubMed ID: 12598607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
    Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H
    J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35.
    Cheng K; Li Z; Fu WY; Wang JH; Fu AK; Ip NY
    J Biol Chem; 2002 Aug; 277(35):31988-93. PubMed ID: 12084709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.
    Nikolic M; Chou MM; Lu W; Mayer BJ; Tsai LH
    Nature; 1998 Sep; 395(6698):194-8. PubMed ID: 9744280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35.
    Hosokawa T; Saito T; Asada A; Ohshima T; Itakura M; Takahashi M; Fukunaga K; Hisanaga S
    J Neurosci Res; 2006 Sep; 84(4):747-54. PubMed ID: 16802322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
    Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators.
    Tang D; Wang JH
    Prog Cell Cycle Res; 1996; 2():205-16. PubMed ID: 9552397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte.
    He Y; Li HL; Xie WY; Yang CZ; Yu AC; Wang Y
    Glia; 2007 Apr; 55(6):573-83. PubMed ID: 17295212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
    Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
    J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of functional domains in the neuronal Cdk5 activator protein.
    Poon RY; Lew J; Hunter T
    J Biol Chem; 1997 Feb; 272(9):5703-8. PubMed ID: 9038181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
    Lee JH; Kim KT
    J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein SET binds the neuronal Cdk5 activator p35nck5a and modulates Cdk5/p35nck5a activity.
    Qu D; Li Q; Lim HY; Cheung NS; Li R; Wang JH; Qi RZ
    J Biol Chem; 2002 Mar; 277(9):7324-32. PubMed ID: 11741927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.